Approved for Short-term IV treatment of acute decompensated heart failure in patients who have not responded adequately to other therapies. Inhibits phosphodiesterase-3 in cardiac and vascular smooth muscle, increasing intracellular cyclic AMP. This results in enhanced cardiac contractility (positive inotropy) and vasodilation, reducing… Side effects, costs, interactions, manufacturer, and…
Loading full data from Know Your Drugs Institute…